Commentary: Which Principles Should Apply for a National Strategy on Rare Diseases? [0.03%]
评论：国家罕见病战略应遵循哪些原则？
Marc-AndrÉ Gagnon
Marc-AndrÉ Gagnon
Lexchin and Sirrs (2024) proposed five relevant principles to guide the use of federal funding for expensive drugs for rare diseases, including funding of outcomes-based risk-sharing agreements (OBRSAs) and proactive commitment and particip...
Federal Funding for Expensive Drugs for Rare Diseases: How Do We Pick and Choose? [0.03%]
罕见疾病的昂贵药物何去何从？政府补助or自费？
Joel Lexchin,Sandra Sirrs
Joel Lexchin
The number of expensive drugs for rare diseases (EDRDs) approved by Health Canada and their contribution to healthcare costs have been rapidly increasing. The federal government has announced a three-year funding commitment of $1.4 billion ...
Fiona Clement,Jason M Sutherland
Fiona Clement
Healthcare is canada's favourite punching bag. Admittedly, Canadian healthcare has many problems and, sometimes, it feels as though the system cannot get anything right. But is all the criticism fair? ...
Rural-Urban Differences in Healthcare Use in Persons With Dementia Between 2000 and 2019: A Quebec Population-Based Study [0.03%]
2000至2019年魁北克痴呆症患者医疗保健利用的城乡差异：基于人口的研究
Geneviève Arsenault-Lapierre,Claire Godard-Sebillotte,Tammy Bui et al.
Geneviève Arsenault-Lapierre et al.
Background: Rural persons with dementia face medical services gaps. This study compares the health service utilization of rural and urban community-dwelling individuals with incident dementia. ...
Comparative Study
Healthcare policy = Politiques de sante. 2024 Feb;19(3):78-95. DOI:10.12927/hcpol.2024.27281 2024
Healthcare Service Utilization and Perceived Gaps: The Experience of French-Speaking 2S/LGBTQI+ People in Manitoba [0.03%]
法语曼尼托巴省2S/ LGBTQI+人在利用保健服务和感知差距方面的体验
Danielle De Moissac,Kevin Prada,Ndeye Rokhaya Gueye et al.
Danielle De Moissac et al.
Ethnolinguistically diverse 2S/LGBTQI+ (two-spirit, lesbian, gay, bisexual, transgender, queer and intersex) populations have unique healthcare needs and experience health inequities compared to their cisgender or heterosexual peers. This c...
Methadone Prescribing Regulation for Opioid Use Disorder in Canada: Evidence for an East-West Policy Divide [0.03%]
加拿大阿片类药物使用障碍的美沙酮处方监管：证据表明存在东西部政策分歧
Chloe Campbell,Kellia Chiu,Abhimanyu Sud
Chloe Campbell
Opioid agonist therapy (OAT) is a key element in the response to opioid-related harms in Canada. In May 2018, Health Canada rescinded the requirement for obtaining a federal exemption for methadone prescribing. This comparative analysis exa...
Commentary: Pricing Cataract (and Other Straightforward) Surgeries - A Policy Perspective to Build Capacity, Value and Innovation [0.03%]
论题：如何对白内障手术（及其他常规手术）进行定价——从政策角度提升医疗_capacity_value_and_innovation
Will Falk
Will Falk
Aligning with Crump and colleagues' (2024) conclusions on cataract surgery, this article champions a level playing field for expanding surgical capacities for straightforward surgeries. It is agnostic toward for-profit or not-for-profit mod...
Trafford R Crump,Gunnar Siljedal,Ezekiel Weis et al.
Trafford R Crump et al.
This paper examines the contentious issue of using contracted surgical facilities (CSFs) for scheduled eye surgeries within Canada's publicly funded healthcare system. Despite the debate over the use of CSFs, there is a stark lack of Canadi...
Commentary: The Conflict Between Protecting Public Health and Raising Tax Revenue [0.03%]
评论：保护公众健康与增加税收之间的冲突
Wayne Hall
Wayne Hall
When Canada created a legal market for cannabis, it gave priority to public health by restricting marketing using branding and promotion via social and other media sources. These restrictions to protect the public from harmful use are under...
Five Years After Cannabis Legalization, Is It Time to Ease Restrictions on Promotion? [0.03%]
大麻合法化五年后，放宽推广限制的时机到了吗？
Jean-François Crépault,Sergio Rueda,Victor Tang
Jean-François Crépault
In the spring of 2024, the federal government is expected to report on its legislative review of the Cannabis Act (2018). One of the most contentious issues is whether to relax restrictions on cannabis promotion. This commentary describes t...